HeadlinesBriefing favicon HeadlinesBriefing

Private Equity 24 Hours

×
8 articles summarized · Last updated: LATEST

Last updated: May 23, 2026, 5:30 AM ET

AI & Tech Fundraising

European AI startups are sprinting toward public markets on the back of aggressive revenue growth claims. Peec, a Berlin-based startup helping brands track their presence in AI search results, more than doubled annualized revenue to $10M in just months, a pace that points to strong private demand for AI-era measurement tools. Across the Atlantic, founders and VCs are inflating ARR figures to present rosier growth narratives to investors, a practice that has become common enough that limited partners now treat it as an open secret. This metric inflation is playing out in deal flow: this week's top 10 funding rounds were dominated by AI, but also included sizable checks for aerospace and defense, fintech, and retail technology, suggesting capital is spreading beyond pure-play AI into adjacent verticals. Meanwhile, Oura filed for a New York IPO after years of growing its smart ring business, a move that will test investor appetite for consumer health hardware at public market valuations.

Healthcare & Medtech PE Activity

Private equity money is flowing into healthcare with particular intensity around pain management and orthopedics. Charterhouse Capital, Iron Path, and Revelar Capital are among the firms building out platforms in the pain management space, while Charlesbank backed a merger between two Nordic medtech manufacturers to create an orthopedics-focused platform. The sector is attracting dealmakers at multiple scales: Churchill Asset Management and 50 South Capital co-led a continuation value extension for Frontenac's industrials holding, extending the firm's ownership of a key CV asset. On the M&A front, Avista and Damier acquired Sanotact, a Belgium-based vitamins company, marking another mid-market consumer health transaction backed by private capital.

Deal Flow & Market Trends

The week reinforced a broader pattern: PE capital is diversifying beyond software into physical-world assets, from vitamins to smart rings to medical devices. Funding rounds spanned frontier AI labs to retail tech, while PE funds pursued pain management and orthopedic platforms with the kind of sectoral conviction that suggests healthcare will remain a core allocation theme for the rest of the year.